Center for Real-World Effectiveness and Safety of Therapeutics (CREST)
Providing actionable real-world evidence to support patients, clinicians, and policymakers in decision making.
Providing actionable real-world evidence to support patients, clinicians, and policymakers in decision making.
Director, Epidemiology
Professor of Epidemiology, Systems Pharmacology
& Translational Therapeutics
Sean Hennessy, PharmD, PhD, directs the Center for Real-World Effectiveness and Safety of Therapeutics (CREST) at Penn Medicine, leveraging healthcare data to study drug safety and efficacy. His research has revealed key health insights, including survival benefits of potassium for loop diuretic users, risks of high-risk drug interactions, and cardiovascular safety concerns in ADHD and depression treatments. His work on Japanese encephalitis vaccine efficacy led to widespread immunization across Asia. A co-developer of innovative study designs, Dr. Hennessy’s contributions have informed FDA policy and Medicare Part D, while advancing pharmacoepidemiology standards globally.
CREST is comprised of nearly 100 investigators, associate and adjunct investigators, and investigators in training who are demonstrated leaders in the development, evaluation, and application of new methods to study the health effects of medications in populations.
Penn and associated faculty members engaged in pharmacoepidemiologic research:
Research staff working with Penn and associated faculty members engaged in pharmacoepidemiologic research:
Penn adjunct faculty and CCEB adjunct scholars engaged in pharmacoepidemiologic research:
Trainees in Penn research training programs (including postdoctoral fellowships), instructors, and research associates, engaged in pharmacoepidemiologic research: